Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

Liver dysfunction in patients with acute pulmonary embolism.

Aslan S, Meral M, Akgun M, Acemoglu H, Ucar EY, Gorguner M, Mirici A.

Hepatol Res. 2007 Mar;37(3):205-13.

PMID:
17362303
2.

Liver function tests in patients with acute heart failure.

Biegus J, Zymliński R, Sokolski M, Nawrocka S, Siwołowski P, Szachniewicz J, Jankowska EA, Banasiak W, Ponikowski P.

Pol Arch Med Wewn. 2012;122(10):471-9. Epub 2012 Oct 4.

3.

[Clinical characteristics and mechanism of liver injury in patients with severe acute respiratory syndrome].

Duan ZP, Chen Y, Zhang J, Zhao J, Lang ZW, Meng FK, Bao XL.

Zhonghua Gan Zang Bing Za Zhi. 2003 Aug;11(8):493-6. Chinese.

PMID:
12939186
4.

Clinical, historical and diagnostic findings associated with right ventricular dysfunction in patients with central and non-massive pulmonary embolism.

Rendina D, De Bonis S, Gallotta G, Piedimonte V, Mossetti G, De Filippo G, Farina F, Vargas G, Barbella MR, Postiglione A, Strazzullo P.

Intern Emerg Med. 2010 Feb;5(1):53-9. doi: 10.1007/s11739-009-0330-8. Epub 2009 Nov 25.

PMID:
19937481
5.

Pulmonary atelectasis: a frequent alternative diagnosis in patients undergoing CT-PA for suspected pulmonary embolism.

Tsai KL, Gupta E, Haramati LB.

Emerg Radiol. 2004 Apr;10(5):282-6. Epub 2004 Mar 17.

PMID:
15290480
6.

Combined use of non-biological artificial liver treatments for patients with acute liver failure complicated by multiple organ dysfunction syndrome.

Li MQ, Ti JX, Zhu YH, Shi ZX, Xu JY, Lu B, Li JQ, Wang XM, Xu YJ.

World J Emerg Med. 2014;5(3):214-7. doi: 10.5847/wjem.j.1920-8642.2014.03.010.

7.

Troponin I as a marker of right ventricular dysfunction and severity of pulmonary embolism.

Amorim S, Dias P, Rodrigues RA, Araújo V, Macedo F, Maciel MJ, Gonçalves FR.

Rev Port Cardiol. 2006 Feb;25(2):181-6.

8.

Percutaneous cardiopulmonary support in pulmonary embolism with cardiac arrest.

Hashiba K, Okuda J, Maejima N, Iwahashi N, Tsukahara K, Tahara Y, Hibi K, Kosuge M, Ebina T, Endo T, Umemura S, Kimura K.

Resuscitation. 2012 Feb;83(2):183-7. doi: 10.1016/j.resuscitation.2011.10.019. Epub 2011 Nov 4.

PMID:
22062683
9.

Volumetric analysis of pulmonary CTA for the assessment of right ventricular dysfunction in patients with acute pulmonary embolism.

Henzler T, Krissak R, Reichert M, Sueselbeck T, Schoenberg SO, Fink C.

Acad Radiol. 2010 Mar;17(3):309-15. doi: 10.1016/j.acra.2009.10.022.

PMID:
20152725
10.

[The changes of serum enzymes and cardiac troponin I in patients with acute pulmonary thromboembolism].

Zhang Y, Yang YH, Pang BS, Wang C.

Zhonghua Jie He He Hu Xi Za Zhi. 2007 Sep;30(9):667-72. Chinese.

PMID:
18070549
11.

B-type natriuretic peptide as an indicator of right ventricular dysfunction in acute pulmonary embolism.

Yardan T, Altintop L, Baydin A, Yilmaz O, Guven H.

Int J Clin Pract. 2008 Aug;62(8):1177-82. Epub 2007 May 30.

PMID:
17537186
12.

Brain natriuretic peptide predicts right heart failure in patients with acute pulmonary embolism.

Krüger S, Graf J, Merx MW, Koch KC, Kunz D, Hanrath P, Janssens U.

Am Heart J. 2004 Jan;147(1):60-5.

PMID:
14691420
13.

Effectiveness of automated quantification of pulmonary perfused blood volume using dual-energy CTPA for the severity assessment of acute pulmonary embolism.

Meinel FG, Graef A, Bamberg F, Thieme SF, Schwarz F, Sommer WH, Neurohr C, Kupatt C, Reiser MF, Johnson TR.

Invest Radiol. 2013 Aug;48(8):563-9. doi: 10.1097/RLI.0b013e3182879482.

PMID:
23519007
14.

[Clinic-epidemiological significance of drug hepatotoxicity in liver disease consultation].

Jmelnitzky AC, Guidi M, Bologna A, Viola M, Soccini C, Barbero R, Belloni P, Apraiz M.

Acta Gastroenterol Latinoam. 2000;30(2):77-84. Spanish.

PMID:
10925723
15.

Longitudinal Study on Liver Functions in Patients with Thalassemia Major before and after Deferasirox (DFX) Therapy.

Soliman A, Yassin M, Al Yafei F, Al-Naimi L, Almarri N, Sabt A, De Sanctis V.

Mediterr J Hematol Infect Dis. 2014 Apr 7;6(1):e2014025. doi: 10.4084/MJHID.2014.025. eCollection 2014.

16.

Liver dysfunction in patients infected with hepatitis C virus undergoing chemotherapy for hematologic malignancies.

Zuckerman E, Zuckerman T, Douer D, Qian D, Levine AM.

Cancer. 1998 Sep 15;83(6):1224-30.

PMID:
9740089
17.

[EzPAP® therapy of postoperative hypoxemia in the recovery room : experiences with the new compact system of end-expiratory positive airway pressure].

Rieg AD, Stoppe C, Rossaint R, Coburn M, Hein M, Schälte G.

Anaesthesist. 2012 Oct;61(10):867-74. doi: 10.1007/s00101-012-2083-4. Epub 2012 Sep 27. German.

PMID:
23011043
18.

Arterial base deficit in pulmonary embolism is an index of severity and diagnostic delay.

Marini C, Di Ricco G, Formichi B, Michelassi C, Bauleo C, Monti S, Giuntini C.

Intern Emerg Med. 2010 Jun;5(3):235-43. doi: 10.1007/s11739-010-0354-0. Epub 2010 Mar 16.

PMID:
20232176
19.

Rheolytic thrombectomy in patients with massive and submassive acute pulmonary embolism.

Chechi T, Vecchio S, Spaziani G, Giuliani G, Giannotti F, Arcangeli C, Rubboli A, Margheri M.

Catheter Cardiovasc Interv. 2009 Mar 1;73(4):506-13. doi: 10.1002/ccd.21858.

PMID:
19235240
20.

Type 1 autoimmune hepatitis: patterns of clinical presentation and differential diagnosis of the 'acute' type.

Ferrari R, Pappas G, Agostinelli D, Muratori P, Muratori L, Lenzi M, Verucchi G, Cassani F, Chiodo F, Bianchi FB.

QJM. 2004 Jul;97(7):407-12.

Items per page

Supplemental Content

Write to the Help Desk